Testing a fluid known as cerebrospinal fluid, or CSF, found surrounding the brain and spinal cord, reveals a lot about brain tumors and the immune response to them. Johns Hopkins neurosurgery department director Chetan Bettegowda and test developer says this …

Can a new test of cerebrospinal fluid be used for many diseases of the brain and spinal cord? Elizabeth Tracey reports Read more →

Tumor components and immune response indicators can be found in cerebrospinal fluid, or CSF, when someone has a brain tumor, in a new test developed by Chetan Bettagowda, director of neurosurgery at Johns Hopkins and one of the test’s developers.  …

Cerebrospinal fluid may hold the keys to brain cancer identification and treatment, Elizabeth Tracey reports Read more →

Your immune system has everything to do with how your body responds to cancer, and brain tumors are no exception. A new test aims to assess that along with characterizing the tumor itself. Chetan Bettegowda, director of neurosurgery at Johns …

What does your immune response have to do with brain tumors? Elizabeth Tracey reports Read more →

Your brain and spinal cord are floating in something called cerebrospinal fluid, or CSF, and when brain tumors develop they shed cells and cellular components into this fluid. A new test developed by director of neurosurgery Chetan Bettegowda at Johns …

Cerebrospinal fluid can tell lots about brain tumors, Elizabeth Tracey reports Read more →

When someone is thought to have a brain tumor procedures to make the diagnosis may be risky or invasive, so a new test developed by Chetan Bettegowda, director of the department of neurosurgery at Johns Hopkins and colleagues is a …

Can assessments of brain cancers be done with cerebrospinal fluid? Elizabeth Tracey reports Read more →

How does listening to patients transform cancer care? In part two of Medicine Made General’s conversation on cancer survivorship, Johns Hopkins researcher Claire Snyder, PhD, MHS, returns to explain how her work helps patients’ voices shape their care. She discusses …

Ep 5 Part 2: The Power of the Patient Voice in Cancer Care | Medicine Made General Read more →

In this episode of Medicine Made General, Johns Hopkins cancer survivorship researcher Claire Snyder, PhD, MHS, joins hosts Dr. Bimal Ashar and Katie Caviness-Crolley to explore what survivorship really means—and why it begins at diagnosis, not after treatment ends. Dr. Snyder discusses how …

Ep 5 Part 1: Caring for the Whole Person: Through Cancer & Beyond | Medicine Made General Read more →

AI assisted colonoscopy, where a computer helped interpret images seen during the procedure, resulted in endoscopists being less adept at recognizing precancerous lesions known as polyps, a recent study finds. Kimmel Cancer Center director William Nelson at Johns Hopkins comments. …

When you have screening colonoscopy should you worry about the endoscopist’s skills? Elizabeth Tracey reports Read more →

If you’ve been treated for early breast cancer your overall risk for recurrence is small, a new large, long term study finds. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says these risks can be pinned to …

Small risks of recurrent breast cancer may exist after treatment, Elizabeth Tracey reports Read more →

Women who’ve had early breast cancer and been treated can likely lay their worries about recurrence to rest, a new study concludes. Johns Hopkins Kimmel Cancer Center director William Nelson says that’s the conclusion of this very large, long term …

Most women who’ve had early breast cancer are not at high risk for recurrence, Elizabeth Tracey reports Read more →